C. Bulabois

Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A Retrospective Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

A. Buzyn, I. Yakoub-Agha, H. Avet-Loiseau, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Diagnosis and treatment of CMV and EBV Reactivation as well as Post-transplant Lymphoproliferative Disorders following Allogeneic Stem Cell Transplantation: An SFGM-TC report].

P. Turlure, S. Alain, F. Suarez, 2013, Pathologie-biologie.

[Impact of anti-HLA antibodies on outcomes of allogeneic stem cell transplantation: a report by the SFGM-TC].

A. Devys, A. Devys, V. Renac, 2014, Pathologie-biologie.

[Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].

A. Ravinet, I. Yakoub-Agha, A. Huynh, 2017, Bulletin du cancer.

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)].

P. Turlure, F. Suarez, M. Rubio, 2014, Pathologie-biologie.

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

A. Duhamel, Z. Marjanovic, M. Rubio, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

J. Bourhis, P. Chevallier, D. Blaise, 2016, Bone Marrow Transplantation.

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

A. Duhamel, Z. Marjanovic, M. Rubio, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

M. Labopin, P. Chevallier, I. Yakoub-Agha, 2014, Bone Marrow Transplantation.